Literature DB >> 15789959

Reliability and construct validity of the SF-36 in Turkish cancer patients.

Rukiye Pinar1.   

Abstract

In this study, we assessed the reliability and construct validity of the SF-36, Turkish version on 419 cancer patients. Cronbach's alpha coefficients surpassed the 0.70 criterions for all subscales indicating good internal consistency. Results of the test-retest method showed that the stability coefficients for the eight subscales of the SF-36 ranged between 0.81 and 0.94. Principal components factor analysis with varimax rotation confirmed the presence of seven factors in the SF-36: physical functioning, role limitations due to physical and emotional problems, mental health, general health perception, bodily pain, social functioning, and vitality. In conclusion, the Turkish version of the SF-36 is a suitable instrument that could be employed in cancer research in Turkey.

Entities:  

Mesh:

Year:  2005        PMID: 15789959     DOI: 10.1007/s11136-004-2393-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  11 in total

Review 1.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

4.  Use of the SF-36 questionnaire in cerebrovascular disease.

Authors:  P Hobson; B Bhowmick; J Meara
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

5.  The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden.

Authors:  M Sullivan; J Karlsson; J E Ware
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

6.  Measuring patients' views: the optimum outcome measure.

Authors:  J E Ware
Journal:  BMJ       Date:  1993-05-29

7.  Short form 36 (SF36) health survey questionnaire: normative data for adults of working age.

Authors:  C Jenkinson; A Coulter; L Wright
Journal:  BMJ       Date:  1993-05-29

8.  Measuring health status in older patients. The SF-36 in practice.

Authors:  S G Parker; S M Peet; C Jagger; M Farhan; C M Castleden
Journal:  Age Ageing       Date:  1998-01       Impact factor: 10.668

9.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

10.  The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

Authors:  A M Garratt; D A Ruta; M I Abdalla; J K Buckingham; I T Russell
Journal:  BMJ       Date:  1993-05-29
View more
  36 in total

1.  Physical activity and health-related quality of life in young adult cancer survivors: a Canadian provincial survey.

Authors:  Lisa J Bélanger; Ronald C Plotnikoff; Alexander Clark; Kerry S Courneya
Journal:  J Cancer Surviv       Date:  2010-09-21       Impact factor: 4.442

2.  Midterm outcome after unilateral approach for bilateral decompression of lumbar spinal stenosis: 5-year prospective study.

Authors:  Halit Cavuşoğlu; Ramazan Alper Kaya; Osman Nuri Türkmenoglu; Cengiz Tuncer; Ibrahim Colak; Yunus Aydin
Journal:  Eur Spine J       Date:  2007-08-22       Impact factor: 3.134

3.  Quality of life assessments with SF 36 in different musculoskeletal diseases.

Authors:  Figen Yilmaz; Fusun Sahin; Ernur Ergoz; Emel Deniz; Cem Ercalik; Serap Dalgic Yucel; Banu Kuran
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 2.980

4.  Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale.

Authors:  Erhan Arif Ozturk; Bilge Gonenli Kocer; Ebru Umay; Aytul Cakci
Journal:  Qual Life Res       Date:  2018-06-07       Impact factor: 4.147

5.  Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.

Authors:  Temitope Olufade; Lisa Gallicchio; Ryan MacDonald; Kathy J Helzlsouer
Journal:  Support Care Cancer       Date:  2014-08-17       Impact factor: 3.603

6.  Restless legs syndrome in hemodialysis patients: association with depression and quality of life.

Authors:  Deniz Tuncel; Fatma Ozlem Orhan; Hayriye Sayarlioglu; Ismet Onder Isık; Uygar Utku; Aytac Dinc
Journal:  Sleep Breath       Date:  2010-07-01       Impact factor: 2.816

7.  Disability of Arm Shoulder and Hand Questionnaire in rheumatoid arthritis patients: relationship with disease activity, HAQ, SF-36.

Authors:  Lale Akbulut Aktekin; Filiz Eser; Bedriye Mermerci Başkan; Filiz Sivas; Simten Malhan; Ergun Öksüz; Hatice Bodur
Journal:  Rheumatol Int       Date:  2010-08-01       Impact factor: 2.631

8.  Comparison of low level laser therapy and extracorporeal shock wave in treatment of chronic lateral epicondylitis.

Authors:  Türkan Turgay; Pınar Günel Karadeniz; Gökhan Bülent Sever
Journal:  Acta Orthop Traumatol Turc       Date:  2020-11       Impact factor: 1.511

9.  Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients.

Authors:  Erem K Basok; Necmettin Atsu; Murat M Rifaioglu; Gulcin Kantarci; Asif Yildirim; Resit Tokuc
Journal:  Int Urol Nephrol       Date:  2008-10-14       Impact factor: 2.370

10.  Evaluation of the psychometric properties of the SF-36 health survey for use among Turkish and Moroccan ethnic minority populations in the Netherlands.

Authors:  Rianne Hoopman; Caroline B Terwee; Walter Devillé; Dirk L Knol; Neil K Aaronson
Journal:  Qual Life Res       Date:  2009-06-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.